A thorough research of the Subcutaneous Neurofibroma Market reveals critical gaps and high-priority areas for both therapeutic development and clinical management. Current research confirms the clinical effectiveness of surgical intervention for symptomatic solitary lesions but highlights its limitations in managing the systemic, chronic burden of multiple, widespread tumors. This key...